FDA Panel's "Misinformation" on Antidepressant Use in Pregnancy
The Brian Lehrer Show
00:00
Controversy Over SSRIs and Women's Mental Health
This chapter examines the contentious dialogue surrounding the FDA panel's remarks about SSRI use during pregnancy. The speakers challenge the view that anxiety and depression in women might be a 'gift' and emphasize the importance of treating mental health issues seriously.
Transcript
Play full episode
